Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | HTR1A | P08908 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.72 |
| ▸ | HTR2C | P28335 | 1/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.72 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.60 |
| ▸ | KRAS | P01116 | 5/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.59 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.59 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.59 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.59 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.59 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.59 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.59 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8637989 | 1.00 | ALDH1A1 (0.72) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL4640353 | 0.88 | ABCB1 (0.63) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL5570622 | 0.88 | ABCB1 (0.63) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL7997556 | 0.87 | TUBB4A (0.62) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL7997553 | 0.87 | TUBB4A (0.62) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL29966256 | 0.86 | CYP1A2 (0.74) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL2743907 | 0.85 | ALDH1A1 (0.77) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL2743909 | 0.85 | ALDH1A1 (0.77) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| SCHEMBL17529421 | 0.85 | TUBB4A (0.59) | ALDH1A1KDM4EHTR1AHPGDGAA | |
| Sinapic Acid Methyl Ether SCHEMBL207442 | 0.84 | KDM4E (1.00) | ALDH1A1KDM4EHTR1AHPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112028856-B | Preparation method of cinepazide maleate intermediate | 康普药业股份有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-112028856-A | Preparation method of cinepazide maleate intermediate | 康普药业股份有限公司 | 2020-12-04 | — | — | CN | claimed |
| CN-109115900-A | The method of LC-MS/MS method measurement (E) 3,4,5- trimethoxy cinnamoyl chloride | 中南粮油食品科学研究院有限公司 | 2019-01-01 | — | — | CN | claimed |
| CN-103239453-A | Maleic acid cinepazide composition | LIAONING YILING KECHUANG BIOLOG MEDICAL TECHNOLOGY CO LTD | 2013-08-14 | — | — | CN | claimed |
| EP-0450892-A1 | Cinnamic acid derivative and external skin treatment preparation containing the same | SHISEIDO COMPANY LIMITED (JP) | 1991-10-09 | — | — | EP | claimed |
| CN-117229205-B | Preparation method and pharmaceutical application of phenyl acrylamide RHbDD1 inhibitor | 中国医学科学院基础医学研究所 | 2025-03-21 | — | — | CN | disclosed |
| CN-112028856-B | Preparation method of cinepazide maleate intermediate | 康普药业股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-112028856-B | Preparation method of cinepazide maleate intermediate | 康普药业股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117229205-A | Preparation method and pharmaceutical application of phenyl acrylamide RHbDD1 inhibitor | 中国医学科学院基础医学研究所 | 2023-12-15 | — | — | CN | disclosed |
| CN-116023247-A | 2-propylene-1 ketone compound and preparation method and application thereof | 暨南大学 | 2023-04-28 | — | — | CN | disclosed |
| US-20210206725-A1 | PIPERLONGUMINE ANALOGUES AND USES THEREOF | BIOVENTURES, LLC | 2021-07-08 | — | — | US | disclosed |
| CN-112028856-A | Preparation method of cinepazide maleate intermediate | 康普药业股份有限公司 | 2020-12-04 | — | — | CN | disclosed |
| US-4450109-A | VASODILATION; CARDIOTONIC AGENTS; HYPOTENSIVE AGENTS | SS PHARMACEUTICAL CO., LTD. (JP) | 1984-05-22 | — | — | US | disclosed |
| EP-0083712-A1 | 1-(3,4,5-Trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives and a process for the preparation thereof | Hokuriku Pharmaceutical Co.,Ltd (JP) | 1983-07-20 | — | — | EP | disclosed |
| US-4369309-A | HYPOTENSIVE AGENTS; UASODILATION; CARDIOVASCULAR DISORDERS | SS PHARMACEUTICAL CO., LTD. (JP) | 1983-01-18 | — | — | US | disclosed |
| US-4001218-A | BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | disclosed |
| US-3987036-A | ACYLATION, CORONARY VASODILATORS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-10-19 | — | — | US | disclosed |
| US-3982011-A | ANTIBIOTICS, ANIMAL GROWTH PROMOTERS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-09-21 | — | — | US | disclosed |
| US-3933826-A | ANALGESICS, VASODILATORS, HYPOTENSIVES | NIPPON CHEMIPHAR CO., LTD. (JA) | 1976-01-20 | — | — | US | disclosed |
| US-3931153-A | BACTERICIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206725-A1 | PIPERLONGUMINE ANALOGUES AND USES THEREOF | AGER, MCL1, TP53 | ALDH1A1 839/4885KDM4E 642/4885HTR1A 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.